| | 1-Piperazinecarboxamide, 4-ethyl-N-[4-[1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-2-pyridinyl]-|4-乙基-N-(4-(1-(四氢-2H-吡喃-4-基)-1H-吡咯并[2,3-C]吡啶-3-基)吡啶-2-基)哌嗪-1-甲酰胺 基本信息 更多信息 |
| 中文名称: | 4-乙基-N-(4-(1-(四氢-2H-吡喃-4-基)-1H-吡咯并[2,3-C]吡啶-3-基)吡啶-2-基)哌嗪-1-甲酰胺 | | 中文同义词: | 4-乙基-N-(4-(1-(四氢-2H-吡喃-4-基)-1H-吡咯并[2,3-C]吡啶-3-基)吡啶-2-基)哌嗪-1-甲酰胺;化合物GNF2133;化合物GNF2133,10 MM DMSO 溶液;GNF2133抑制剂,98%;GNF2133抑制剂，98% | | 英文名称: | 1-Piperazinecarboxamide, 4-ethyl-N-[4-[1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-2-pyridinyl]- | | 英文同义词: | β-cell,RIP-DTA mice,Inhibitor,insulin secretion,GNF2133,inhibit,Dual specificity tyrosine regulated kinase,glucose disposal,Dual specificity tyrosine phosphorylation regulated kinase,CD-1 mice,GNF 2133,DYRK,GNF-2133,orally active;4-Ethyl-N-(4-(1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl)pyridin-2-yl)piperazine-1-carboxamide;4-ethyl-N-{4-[1-(oxan-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]pyridin-2-yl}piperazine-1-carboxamide;GNF2133, 10 mM in DMSO;1-Piperazinecarboxamide, 4-ethyl-N-[4-[1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-2-pyridinyl]- | | CAS号: | 2561414-56-8 | | 分子式: | C24H30N6O2 | | 分子量: | 434.53 | | EINECS号: | | ![1-Piperazinecarboxamide, 4-ethyl-N-[4-[1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-2-pyridinyl]-|4-乙基-N-(4-(1-(四氢-2H-吡喃-4-基)-1H-吡咯并[2,3-C]吡啶-3-基)吡啶-2-基)哌嗪-1-甲酰胺](/CAS/20211123/GIF/2561414-56-8.gif) |
|
| 按国家浏览1-Piperazinecarboxamide, 4-ethyl-N-[4-[1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-2-pyridinyl]-国外供应商 |
中国供应商 |
|
1-Piperazinecarboxamide, 4-ethyl-N-[4-[1-(tetrahydro-2H-pyran-4-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-2-pyridinyl]- 推荐供应商 |
|
|
建议您优先选择企业会员,我们对企业会员产品有严格审核。 |
|
1
|